Description
| COMPOSITION: | Each film coated extended release tablet contains Ranolazine 500 mg. |
| FORMULATION: | test |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Razocard contains sustain release Ranolazine, a second line anti anginal drug with a novel mechanism of action that offers freedom from most adverse hemodynamic effects. Razocard is indicated as add-on therapy for the symptomatic treatment of chronic angina i.e. long standing chest pain. |
| SIDE EFFECTS: | The common side effects are dizziness, headaches, nausea, debility, and constipation. |
| DOSAGE/DIRECTIONS FOR USE: | AS PRESCRIBED BY PHYSICIAN |
Reviews
There are no reviews yet.